Palatin Technologies
PTN
#10978
Rank
C$12.8 M
Marketcap
C$7.19
Share price
0.79%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Total assets

Total assets on the balance sheet as of March 2026 : C$18.5 Million

According to Palatin Technologies's latest financial reports the company's total assets are C$18.5 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Palatin Technologies - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-06-30C$4.44 M-69.74%
2024-06-30C$14.68 M-38.14%
2023-06-30C$23.74 M-48.87%
2022-06-30C$46.43 M-44.32%
2021-06-30C$83.39 M-27.76%
2020-06-30C$0.11 B-15.79%
2019-06-30C$0.13 B167.23%
2018-06-30C$51.3 M-30.51%
2017-06-30C$73.82 M424.73%
2016-06-30C$14.06 M-61.74%
2015-06-30C$36.77 M174.41%
2014-06-30C$13.4 M-49.16%
2013-06-30C$26.36 M381.18%
2012-06-30C$5.47 M-73.15%
2011-06-30C$20.4 M55.59%
2010-06-30C$13.11 M-13.52%
2009-06-30C$15.16 M-22.15%
2008-06-30C$19.48 M-57.04%
2007-06-30C$45.34 M1.99%
2006-06-30C$44.46 M1.85%
2005-06-30C$43.65 M17.93%
2004-06-30C$37.01 M20.96%
2003-06-30C$30.6 M63.37%
2002-06-30C$18.73 M-13.19%
2001-06-30C$21.57 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$281.30 B 1,520,175.53%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$162.06 B 875,744.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$7.49 B 40,421.58%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
C$56.57 M 205.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.05 B 16,427.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$2.09 B 11,197.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
C$8.38 M-54.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.80 B 4,254.49%๐Ÿ‡บ๐Ÿ‡ธ USA